company background image
2007 logo

Hualan Biological Engineering SZSE:002007 Stock Report

Last Price

CN¥19.81

Market Cap

CN¥35.4b

7D

-0.6%

1Y

-6.2%

Updated

28 Mar, 2024

Data

Company Financials +

Hualan Biological Engineering Inc.

SZSE:002007 Stock Report

Market Cap: CN¥35.4b

2007 Stock Overview

Hualan Biological Engineering Inc., a biopharmaceutical company, researches, develops, produces, and commercializes plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics in the People’s Republic of China.

2007 fundamental analysis
Snowflake Score
Valuation4/6
Future Growth3/6
Past Performance5/6
Financial Health5/6
Dividends4/6

Hualan Biological Engineering Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hualan Biological Engineering
Historical stock prices
Current Share PriceCN¥19.81
52 Week HighCN¥25.09
52 Week LowCN¥16.51
Beta0.30
1 Month Change0.61%
3 Month Change-10.48%
1 Year Change-6.20%
3 Year Change-50.62%
5 Year Change-13.66%
Change since IPO1,820.05%

Recent News & Updates

Is Hualan Biological Engineering (SZSE:002007) Using Too Much Debt?

Feb 27
Is Hualan Biological Engineering (SZSE:002007) Using Too Much Debt?

Recent updates

Is Hualan Biological Engineering (SZSE:002007) Using Too Much Debt?

Feb 27
Is Hualan Biological Engineering (SZSE:002007) Using Too Much Debt?

Shareholder Returns

2007CN BiotechsCN Market
7D-0.6%-6.3%-4.9%
1Y-6.2%-21.2%-16.6%

Return vs Industry: 002007 exceeded the CN Biotechs industry which returned -21.2% over the past year.

Return vs Market: 002007 exceeded the CN Market which returned -16.6% over the past year.

Price Volatility

Is 2007's price volatile compared to industry and market?
2007 volatility
2007 Average Weekly Movement3.9%
Biotechs Industry Average Movement8.1%
Market Average Movement8.2%
10% most volatile stocks in CN Market11.5%
10% least volatile stocks in CN Market5.1%

Stable Share Price: 002007 has not had significant price volatility in the past 3 months.

Volatility Over Time: 002007's weekly volatility (4%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
19923,243Bei Fanhttps://www.hualanbio.com

Hualan Biological Engineering Inc., a biopharmaceutical company, researches, develops, produces, and commercializes plasma products, viral vaccines, bacterial vaccines, and recombinant proteins and other biologics in the People’s Republic of China. Its blood products comprise human albumin, human immunoglobulin, intravenous human immunoglobulin, rabies immunoglobulin, hepatitis B human immunoglobulin, tetanus human immunoglobulin, human prothrombin complex, human coagulation factor VIII, lyophilized human thrombin for external use, freeze-dried human fibrin glue for surgery, and human fibrinogen. The company’s vaccines consist of influenza virus split vaccine, recombinant hepatitis B vaccine, ACYW135 meningococcal polysaccharide vaccine, A H1N1 influenza virus split vaccine, and quadrivalent influenza virus split vaccine.

Hualan Biological Engineering Inc. Fundamentals Summary

How do Hualan Biological Engineering's earnings and revenue compare to its market cap?
2007 fundamental statistics
Market capCN¥35.42b
Earnings (TTM)CN¥1.24b
Revenue (TTM)CN¥4.83b

29.1x

P/E Ratio

7.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
2007 income statement (TTM)
RevenueCN¥4.83b
Cost of RevenueCN¥1.70b
Gross ProfitCN¥3.13b
Other ExpensesCN¥1.88b
EarningsCN¥1.24b

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

Mar 30, 2024

Earnings per share (EPS)0.68
Gross Margin64.78%
Net Profit Margin25.75%
Debt/Equity Ratio7.0%

How did 2007 perform over the long term?

See historical performance and comparison

Dividends

1.5%

Current Dividend Yield

44%

Payout Ratio
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.